
Fortive (FTV) Stock Forecast & Price Target
Fortive (FTV) Analyst Ratings
Bulls say
Fortive's financial performance demonstrates resilience, with 2024 revenue reaching approximately $6.2 billion and specific sales from the Advanced Healthcare Solutions (AHS) segment growing 1.9% year-over-year, despite challenges in healthcare spending due to reimbursement policy changes. The company reported a notable increase in adjusted EBITDA to $309 million, reflecting a strong year-over-year growth rate of 10.4%, bolstered by advantageous stock compensation adjustments and efficient cost management. Additionally, the success in North America, where sales increased by 4% due to demand in professional instrumentation and healthcare equipment, highlights Fortive's robust market position and continued opportunities for growth.
Bears say
Fortive's outlook appears negative due to several concerning financial metrics, particularly in earnings per share (EPS), which are projected to show a sequential decline in 3Q25 compared to 2Q25. Additionally, the company's adjusted gross profit and margin have been adversely impacted, with a year-over-year decline attributed to tariff cost headwinds, indicating potential challenges in sustaining profitability. Furthermore, broader trends in energy consumption show significant declines, which could adversely affect demand across the end markets Fortive serves.
This aggregate rating is based on analysts' research of Fortive and is not a guaranteed prediction by Public.com or investment advice.
Fortive (FTV) Analyst Forecast & Price Prediction
Start investing in Fortive (FTV)
Order type
Buy in
Order amount
Est. shares
0 shares